Page last updated: 2024-09-03

razadyne and Idiopathic Parkinson Disease

razadyne has been researched along with Idiopathic Parkinson Disease in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Becher, PG; Beuchat, J; Gademann, K; Jüttner, F	1
Mohamed, T; Rao, PP; Yeung, JC	1

Other Studies

2 other study(ies) available for razadyne and Idiopathic Parkinson Disease

Article	Year
Nostocarboline: isolation and synthesis of a new cholinesterase inhibitor from Nostoc 78-12A. Journal of natural products, 2005, Volume: 68, Issue:12 Topics: Brain; Butyrylcholinesterase; Carbolines; Cholinesterase Inhibitors; Galantamine; Humans; Inhibitory Concentration 50; Molecular Structure; Nostoc; Parkinson Disease	2005
Development of 2-substituted-N-(naphth-1-ylmethyl) and N-benzhydrylpyrimidin-4-amines as dual cholinesterase and Aβ-aggregation inhibitors: Synthesis and biological evaluation. Bioorganic & medicinal chemistry letters, 2011, Oct-01, Volume: 21, Issue:19 Topics: Acetylcholinesterase; Amyloid beta-Peptides; Benzhydryl Compounds; Butyrylcholinesterase; Cholinesterase Inhibitors; Dose-Response Relationship, Drug; Drug Design; Drug Evaluation, Preclinical; Humans; Models, Molecular; Molecular Structure; Molecular Targeted Therapy; Parkinson Disease; Plaque, Amyloid; Pyrimidines; Structure-Activity Relationship	2011

Article

Year

Nostocarboline: isolation and synthesis of a new cholinesterase inhibitor from Nostoc 78-12A.

Journal of natural products, 2005, Volume: 68, Issue:12

Topics: Brain; Butyrylcholinesterase; Carbolines; Cholinesterase Inhibitors; Galantamine; Humans; Inhibitory Concentration 50; Molecular Structure; Nostoc; Parkinson Disease

2005

Development of 2-substituted-N-(naphth-1-ylmethyl) and N-benzhydrylpyrimidin-4-amines as dual cholinesterase and Aβ-aggregation inhibitors: Synthesis and biological evaluation.

Bioorganic & medicinal chemistry letters, 2011, Oct-01, Volume: 21, Issue:19

Topics: Acetylcholinesterase; Amyloid beta-Peptides; Benzhydryl Compounds; Butyrylcholinesterase; Cholinesterase Inhibitors; Dose-Response Relationship, Drug; Drug Design; Drug Evaluation, Preclinical; Humans; Models, Molecular; Molecular Structure; Molecular Targeted Therapy; Parkinson Disease; Plaque, Amyloid; Pyrimidines; Structure-Activity Relationship

2011